A recent Dear Abby column highlights a dilemma many families face: how to handle a disruptive sibling while preserving long-held family ties. One reader’s wish to keep the peace underscores the complex responsibilities that often accompany familial relationships.

Groundbreaking news from Immusoft reveals the treatment of the world’s first patient with a B cell-based therapy. With support from the FDA and ARM, the company showcases a next-generation approach focusing on scalability and re-dosability.

A newly approved weight-loss drug, Foundayo (orforglipron), has arrived months ahead of schedule after gaining FDA clearance in just 50 days. The swift approval signals a growing momentum in the development of anti-obesity treatments.

Esperion Therapeutics has completed its acquisition of Corstasis Therapeutics, bringing the FDA-approved Enbumyst nasal spray into its cardiovascular portfolio. This first-in-class nasal spray loop diuretic helps manage fluid retention for congestive heart failure, marking a new step in Esperion’s plan to address the growing global burden of cardiometabolic disease. Executives anticipate that Enbumyst will bolster the company’s commercial capabilities and revenue growth.

Neutrolis, Inc. has released positive results from the Phase 1a portion of its LIBERATE-I trial, spotlighting NTR-1011’s potential in dismantling harmful Neutrophil Extracellular Traps (NETs). This first-in-class DNASE1L3 fusion protein aims to address chronic inflammatory pathways without compromising the immune system.

A husband’s affair with a mutual friend has left one marriage reeling and a friendship in turmoil. While the wife has found a path to forgiveness, the news of a baby on the way adds a daunting new twist to an already fragile situation.

A mother in Texas grapples with her daughter’s unfounded blame, while a 35-year-old woman contemplates a life-changing decision about intimacy. Dear Abby offers counsel on confronting false accusations, navigating personal struggles, and acknowledging the significance of Passover.

In this advice-column dilemma, a reader grapples with leaving a spouse after a medical diagnosis. Turning to R. Eric Thomas’s “Asking Eric” column, the individual confronts guilt, responsibility, and the desire for autonomy.

A shocked mother grapples with her 22-year-old daughter’s relationship with a 54-year-old boss. Bound by a promise of secrecy to her older daughter, she struggles to voice her concerns as the family edge closer to a confrontation.

In this opinion piece, the author grapples with a wave of intense sadness while pointing a finger at the internet algorithm. Personal reflections hint at a previous column, underscoring how online content might deepen our emotions in surprising ways.

Brii Biosciences announced full-year 2025 results, emphasizing progress in its hepatitis B treatments and a robust cash position of US$276.1 million. The Company’s Phase 2b HBV trials, ENRICH and ENHANCE, have fully enrolled and are poised for key data readouts in the second half of 2026.

A traveler reveals how her perceived “ugliness” allows her to move through unfamiliar places with less harassment. Her first-person reflection, shared online, shines light on how appearance can influence personal experiences and safety.

Research suggests that the time of day when certain treatments—such as cancer therapies or vaccines—are given can influence their effectiveness. Scientists are examining how the body’s internal clock, or circadian rhythm, might be the key to unlocking better patient outcomes.

IgA nephropathy is a silent attack on the kidneys that often goes unnoticed. With new treatments on the horizon, early diagnosis could save countless lives by preventing further damage and prolonging kidney function.

A new generation of medications first developed for diabetes is now offering hope for chronic kidney disease patients. Three types of these drugs, including one famously known as Ozempic, are transforming the outlook for individuals who have long waited for more effective treatment options.

A father who once saw his daughter more frequently finds his new swing shift schedule leaves him with limited time. Now confined to every other weekend visits, he wonders how to cope with the constraints and keep his bond strong.

Walking has gained attention as a straightforward way to manage stress and bolster overall well-being. By putting one foot in front of the other, people can experience both physical and mental benefits in their daily routines.

A former Notre Dame tennis standout from University Park, Texas, lost all four of his limbs after severe pneumonia complications in 2022. Despite this life-altering challenge, he leans on his family and unwavering resolve to remain hopeful and engaged.

Midlife can bring sudden shifts in mood that leave many women feeling unsettled. This article explores how quickly emotions can swing and emphasizes one key message: you’re not alone—and definitely not going crazy.

A reader concerned about heart health poses questions after being told to use xylitol-sweetened gum for dry mouth. Medical professionals respond to clarify whether the sweetener has any detrimental impact on the cardiovascular system.

At 35, runner Erica Blackburn discovered that her longtime passion was jeopardized by varicose veins. This article explores how she found relief through a targeted treatment, enabling her to return to the active life she loves.